Initial assessment of outpatient visits to the cannabis abuse clinics


Initial assessment of outpatient visits to the cannabis abuse clinics

Tendances n° 50, OFDT, 4 p.
September 2006

Within the framework of the government's action plan against illicit drugs, tobacco and alcohol (2004-2008), a prevention programme against cannabis use has been up. In February 2005, this programme included an awareness- raising media campaign and the setting up of specific outpatient clinics targeting people who have, or think they may have, an addiction to cannabis. These "riskassessment clinics" have been closely associated with the existing addiction treatment system.
The aim of these "clinics for young users" has been to offer young people an assessment of their consumption and a diagnosis of harmful use; to offer personalised information and advice to "high risk" users, to provide shortterm care to young people reporting harmful use without social or psychiatric complications; to accompany and provide counselling advice to young people if their situation warrants it; to offer support to parents having difficulties in coping with their children's consumption; to offer, if necessary, joint support for parents and children.
The objective of the present survey is to provide an insight into the population attending the clinics, by comparison with cannabis users in the general population. What specific treatment do these outpatient clinics offer to people with cannabis-related problems? How are they effective as a means to access care structures?

Author :
Ivana Obradovic

Download the PDF file (648 Ko)

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.